Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation
about
Blood transcriptomics: applications in toxicologyCirculating mitochondrial biomarkers for drug-induced liver injuryPathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives.Predose and Postdose Blood Gene Expression Profiles Identify the Individuals Susceptible to Acetaminophen-Induced Liver Injury in RatsAnalysis of the transcriptome in molecular epidemiology studiesUse of transcriptomics in understanding mechanisms of drug-induced toxicityMechanisms of drug-induced liver injury: from bedside to bench.Identification of a metabolic biomarker panel in rats for prediction of acute and idiosyncratic hepatotoxicity.Understanding lactic acidosis in paracetamol (acetaminophen) poisoning.The proper use of acetaminophen.Identification and characterization of adverse effects in 21st century toxicologyTranslational biomarkers of acetaminophen-induced acute liver injuryIdentification of Identical Transcript Changes in Liver and Whole Blood during Acetaminophen Toxicity.Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophenThe application of metabonomics to predict drug-induced liver injury.The potential of cytokines as safety biomarkers for drug-induced liver injury.Transcriptional profiling to identify biomarkers of disease and drug response.Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity.Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.The generation, detection, and effects of reactive drug metabolites.Contributions of pharmacogenetics and transcriptomics to the understanding of the hypersensitivity drug reactions.The importance of the ionic product for water to understand the physiology of the acid-base balance in humans.Transcriptomic studies on liver toxicity of acetaminophen.Contribution of new technologies to characterization and prediction of adverse effects.A descriptive analysis of aspartate and alanine aminotransferase rise and fall following acetaminophen overdose.Rational Design of Novel Pyridinol-Fused Ring Acetaminophen AnaloguesCSH guidelines for the diagnosis and treatment of drug-induced liver injuryIdentification of urinary microRNA profiles in rats that may diagnose hepatotoxicity.Antidote removal during haemodialysis for massive acetaminophen overdose.Dissecting the molecular pathophysiology of drug-induced liver injury.Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration
P2860
Q23919602-A03FD2BA-DC37-4B52-A2B3-C1F10161277FQ26778353-E1914197-A083-4DCE-A54A-3865E561E8D7Q27690772-4C52E0CD-2133-4FD1-BCBF-85DC17F01474Q28550555-9E316862-DF5F-4E17-B987-15F07FECC150Q28817795-491AD3C3-BA63-4A48-98BD-43C971B8AD73Q33909001-5358E9FA-15F6-45B7-B848-D9109CC1602FQ34169362-FFF04DBC-E5CA-431D-80C5-6BBFDE943178Q34376979-25636E8B-9C43-40CD-BAD7-376C7EBAF809Q34476057-8317F1D4-54B2-42D3-A9A8-E6E8725C6D03Q35572609-25427F1B-28E2-436E-809C-CBF9B4D39510Q35839538-22D24554-1D13-48F5-B741-F88FE2AFA0CEQ36001451-B852A19D-F842-4764-A4B5-84B2EC367458Q36206111-41E054E3-B225-477A-8A87-17B3EE55D6D1Q36669589-EF9496EC-27F2-41ED-BCED-E7777CEDBD66Q37776403-FF1CE946-E955-4C97-A60A-2774B01FAC95Q37778758-EE355AA2-58EC-4BD7-A492-5936C31523EEQ37844547-01C8B2E7-7FB0-4F4C-B5F9-8C211C51B04CQ37862739-D83F29D7-4FFC-4486-A9BA-36D3A60E5619Q37892531-E2C3EDCD-CB58-4D4D-BBEE-7FA9BBB13981Q38054629-2ABAB92C-3AE7-4F2B-AA5C-FD41319D2926Q38182188-938D9CBA-13A5-4082-B112-E777ABA51A5CQ38216034-2E74B791-181A-4A3F-8401-631050566304Q38246626-3A675D6B-A613-478B-BEC6-9FAE66FBAA5DQ38329939-3ACE5973-3912-4884-A56D-D0A77AAB9E58Q38570734-159C5EE2-D396-4DA1-A15D-D850780AFE40Q41895629-1B002091-2A44-4D84-86DB-18B74400955AQ42354312-808234C1-CB71-4EFB-9719-A6B341576762Q42723585-C21348E8-1AB7-4C23-9B8B-A5CE3BC935FDQ45459276-B2CF1947-34ED-4902-9B24-0A1236406061Q52720493-50622064-055F-4A3C-B33B-607FB7E52906Q57477190-9684A1C5-888A-4579-B1F5-470B4A7956C2
P2860
Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@ast
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@en
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@nl
type
label
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@ast
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@en
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@nl
prefLabel
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@ast
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@en
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@nl
P2093
P2860
P356
P1433
P1476
Acetaminophen dosing of humans ...... ired oxidative phosphorylation
@en
P2093
Jack Newton
Jason H Winnike
Jeffrey Macdonald
Joel Parker
Kevin Gerrish
Mark Russo
Paul B Watkins
Richard S Paules
Rick D Fannin
Ruchir Shah
P2860
P304
P356
10.1002/HEP.23330
P407
P577
2010-01-01T00:00:00Z